ABPC (Ampicillin) and SBT (Sulbactam) are β-lactam antibiotics that have been observed to influence GABAergic neurotransmission, potentially aggravating seizure activity. A recent case study involving an 84-year-old male patient with status epilepticus demonstrated significant increases in both the frequency and duration of seizures following the administration of ABPC/SBT.
The patient underwent continuous video electroencephalography (EEG) monitoring, which revealed:
Statistical analysis indicated a significant increase in seizure frequency (p = 0.047) and a tendency towards increased duration (p = 0.079) after the administration of ABPC/SBT, suggesting a direct impact on seizure activity.
The proposed mechanism for the seizure aggravation involves the noncompetitive binding of β-lactams to GABAA receptors, disrupting inhibitory synaptic neurotransmission. This disruption can lead to excitotoxicity, which is particularly concerning in patients with pre-existing neurological conditions.
This case study highlights the potential for ABPC/SBT to exacerbate seizure activity through disruption of GABAergic neurotransmission. Continuous EEG monitoring is crucial for evaluating seizure severity and understanding the effects of pharmacological interventions in patients with epilepsy.
For further reading, see the detailed case study: Seizure aggravation by ampicillin/sulbactam in an elderly patient with status epilepticus [2025]
import pandas as pd import plotly.express as px data = {'Time Period': ['Before ABPC/SBT', 'After ABPC/SBT'], 'Number of Seizures': [3.2, 7.3], 'Duration of Seizures (s)': [199, 406]} df = pd.DataFrame(data) fig = px.bar(df, x='Time Period', y=['Number of Seizures', 'Duration of Seizures (s)'], title='Seizure Frequency and Duration Before and After ABPC/SBT Administration') fig.show()